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Abstract 
The main prerequisites for the use of biotinylated ligands to study the expression of growth factor receptors on 
heterogeneous cell populations, such as peripheral blood or bone marrow, by flow cytometric methods, are that the 
biotinylated ligand retains its binding ability and that binding of the biotinylated ligand to the receptor does not 
inhibit the subsequent interaction of biotin with fluorescently tagged avidin or streptavidin. Using interleukin-2 
(IL-2), we compared the usefulness of various biotinylation reagents, NHS-biotin. S-NHS-biotin, S-NHS-LC-biotin, 
DBB and photobiotin, and developed optimal biotinylation conditions for the preparation of biologically active 
biotin-labeled IL-2 and the detection of IL-2 receptor expressing cells by flow cytometry. As determined by spot blot 
analysis, biotinylation of IL-2 was most efficient at the highest biotin-to-protein (B:Pl ratio used. At a B:P ratio of 
100, most of the biological activity of IL-2 was retained when S-NHS-LC-biotin was used. In contrast, most of the 
biological activity of IL-2 samples that were labeled with NHS-biotin or photobiotin was lost under these conditions. 
Biotin-labeled IL-2 preparations were tested in order to detect IL-2 receptors on IL-2 dependent CTLL-2 cells by 
flow cytometry after sequential staining with the biotinylated IL-2 and fluorescence tagged streptavidin. A high B:P 
ratio generally resulted in a high specific fluorescence intensity of the cells, particularly when S-NHS-LC-biotin was 
used as the biotinylation reagent. Biotin-IL-2 could also be used to detect IL-2 receptors expressed by lymphocytes 
in peripheral blood and bone marrow. Comparison of staining of lymphocytes with biotinylated IL-2 and an antibody 
against the IL-2 receptor cy chain demonstrated that only a subset of the cells that showed a strong fluorescence 
signal after staining with biotinylated IL-2 expressed high numbers of the IL-2 receptor (Y chain. This is in agreement 
with the expression of functional IL-2 receptors on resting T cells and NK cells which do not express the (Y chain. 
Abbreviations: B:P ratio, biotinprotein ratio; FACS, fluorescence activated cell sorter; GF, growth factor; IL-2, interleukin-2; 
NHS-biotin. N-hydroxy succinimide ester of biotin; S-NHS-biotin, N-hydroxysulfo-succinimide ester of biotin; S-NHS-LC-biotin, 
sulfosuccinimidyl-6-(biotinamido) hexanoate; DBB, p-diazobenzoyl biocytin precursor; photobiotin, photoactivatible biotin; PBL, 
peripheral blood lymphocytes: PHA, phytohemagglutinin. 
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After stimulation with PHA, virtually all lymphocytes expressed the (Y chain, whereas only part of these cells showed 
a strong fluorescence signal after staining with biotin-IL-2, while the rest of the cells had very low numbers of IL-2 
binding sites. Our results demonstrate that, in addition to staining individual receptor subunits with antibodies, 
staining with biotinylated IL-2 is a useful indicator of functional IL-2 receptor expression. 
Keywords: Biotin; Growth factor; Receptor; IL-2; Flow cytometry 
1. Introduction 
Growth factors control the growth, differentia- 
tion and maturation of hemopoietic cells as well 
as, in many cases, the functional activity of ma- 
ture end cells, by binding to specific cell surface 
receptors. To examine the target cell specificity 
of growth factors (GF) and the presence of GF 
receptors, in vitro culture systems are used to 
study biological responses (Sonoda et al., 1988; 
Warren et al., 1989; Ishida et al., 1990, as well as 
direct methods to study receptor expression. Di- 
rect receptor labeling studies can be performed 
using radiolabeled GF (Foxwell et al., 1988a; 
Nicola et al., 1988; Park et al., 1989) with the 
advantage that only functionally intact GF recep- 
tors are labeled. However, because ‘251-labeled 
GF are usually quantified as mean number of 
receptors per cell, these studies are of limited use 
for heterogeneous cell populations. Receptor ex- 
pression on subsets of cells in heterogeneous 
populations can be studied using a fluorescence 
activated cell sorter (FACS) when cells are la- 
beled with antibodies against the receptors 
(Weil-Hillman et al., 19901, and double-stained 
for other markers. However, many receptors con- 
sist of several different subunits, and the expres- 
sion of more than one subunit is often required 
to generate functional, high affinity receptors 
(Takeshita et al., 1992b; Ishii et al., 1994; Naka- 
mura et al., 1994; Nelson et al., 1994). In addi- 
tion, some receptors share subunits, e.g. the high 
affinity receptors for human IL-3, GM-CSF and 
IL-5 (Kitamura et al., 1991; Tavernier et al., 
1991), and the high affinity receptors for IL-2, 
IL-4 and IL-7 (Kawahara et al., 1994; Kondo et 
al., 1993; Noguchi et al., 1993; Russell et al., 
1993). Since antibodies usually recognize only one 
of the constituents of a receptor complex, anti- 
body binding may not always be indicative of 
expression of functional receptors. 
Instead of antibodies or radiolabeled GF, bi- 
otinylated GF may be used (Foxwell et al., 1988b; 
Yamasaki et al., 1988; Newman et al., 1989; Pe- 
ters and Norback, 1990; Wognum et al., 1990) to 
combine the advantages of both other methods. 
Biotin is a small molecule of 244 Daltons, which 
can easily be coupled to proteins such as GF. The 
strong interaction between biotin and the egg 
white protein avidin, or the bacterial protein 
streptavidin, can be used to detect binding of 
biotinylated GF to target cells (Wilchek and 
Bayer, 1988). By such a method, functionally in- 
tact receptors are labeled and the cells can be 
analyzed by flow cytometry and sorted using a 
FACS. The efficiency of this approach depends 
on the efficiency of the biotinylation reaction and 
on its effect on the binding affinity and, thus, on 
the biological activity. 
Many different kinds of biotinyl derivatives are 
availabie. For biotinylation of proteins, the N-hy- 
droxy succinimide ester of biotin (NHS-biotin) or 
its water soluble analog N-hydroxysulfo-succini- 
mide biotin (S-NHS-biotin), both of which bind 
primarily to lysine residues under alkaline condi- 
tions, are possibly the most often used (Newman 
et al., 1989; Pieri and Barritault, 1991). Variants 
with an extended spacer arm (S-NHS-long chain-, 
S-NHS-LC-biotin) can be used to reduce the 
effect of steric hindrance (Hnatowich et al., 1987). 
If a sufficient number of lysine residues is not 
available, or when labeling of lysine causes 
changes of the biological activity of the protein, 
other classes of reactive biotin derivatives can be 
used to biotinylate other functional groups. Ty- 
rosines or histidines can be labeled with p-di- 
azobenzoyl biocytin (DBB) (Wilchek et al., 1986). 
Sulfhydryls can be biotinylated with N-iodoace- 
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tyl-IV’-biotinyl-hexanediamine, or with N-[6-(bio- 
tinamido)hexyl]-3-(2-pyridyldithio) propionamide 
(iodoacetyl-biotin and biotin-HPDP, respectively). 
An advantage of biotin-HPDP is, that the S-S 
bridge which is formed by the biotinylation reac- 
tion can be cleaved to remove the biotin (Shim- 
kus et al., 1985), which may be useful to recover 
biotinylated proteins from avidin affinity columns. 
Cleaving off biotins from proteins is also possible 
when sugar residues on glycoproteins are biotiny- 
0 
K 
HN NH 
B 
c HLl&o,pSO. Na+ 
0 0 
0 
K 
HN NH 
Fig. 1. Structure of the different biotinyl derivatives that were used in this study. A: NHS-biotin; B: S-NHS-biotin; (“: 
S-NHS-LC-biotin; D: DBB; and E: photobiotin. 
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lated using biotin hydrazide (O’Shannessy et al., 
1984; Wognum et al., 19901. Another biotinyla- 
tion method uses photobiotin, a photo-activatible 
analog of biotin (Forster et al., 1985; Lacey and 
Grant, 1987) which forms stable (presumably co- 
valent) linkages when illuminated. 
In this study, we have compared the effect of 
conjugation with different biotin derivatives on 
the biological activity as well as on the receptor 
binding ability and resulting labeling intensity of 
IL-2 and examined the application of biotinylated 
IL-2 to detect receptor expression on subsets of 
peripheral blood and bone marrow cells. 
2. Materials and methods 
2.1. Biotinylation 
E. coli derived human recombinant IL-2 
(specific activity 2.8 x lo6 U/mg; Biogen, 
Geneva, Switzerland) was biotinylated using dif- 
ferent biotin derivatives (Fig. 1). NHS-biotin, the 
water soluble S-NHS-biotin and its extended 
spacer arm analog S-NHS-LC-biotin (all from 
Pierce, Rockford IL, USA) were dissolved in 
dimethyl sulfoxide (DMSO) or in 0.1 M carbon- 
ate-bicarbonate buffer pH 8.5. DBB precursor 
(Calbiochem, San Diego, CA, USA) was dis- 
solved in DMSO, and prepared according to the 
manufacturer’s instructions. IL-2 was diluted in 
0.1 M carbonate-bicarbonate buffer pH 8.5 (for 
the different NHS-biotins) or in 0.05 M borate or 
carbonate buffer pH 9.0 (for DBB). Biotin was 
added to the GF solution to obtain a molar 
biotin:protein (B:P) ratio of 100, 20, or 4 during 
the reaction. As controls, samples were mock-bio- 
tinylated (at B:P 01 by just adding DMSO or 
buffer without biotin. The biotinylation reactions 
were allowed to take place for 1.5 h (DBB) or 3 h 
(NHS-biotin) at room temperature, or for 3 h on 
ice (S-NHS-biotins). Photoactivatible biotin (pho- 
tobiotin, stock solution of 1 mg/ml; Vector Labo- 
ratories, Burlingame CA, USA1 was used, accord- 
ing to the manufacturer’s instructions at B:P re- 
action ratios of lO:l, 1:l and 1:lO (w/w; corre- 
sponding to molar B:P ratios of approximately 
250, 25 and 2.5, respectively). These reaction 
mixtures and a control without photobiotin were 
illuminated with UV light for 30 min on ice using 
a mercury arc lamp. The reaction was stopped by 
adding an equal volume of 0.1 M Tris pH 9.0. 
The remaining free biotin molecules in the sam- 
ples were removed either by size exclusion chro- 
matography, using a PD-10 column containing 
Sephadex G-25 (Pharmacia, Uppsala, Sweden), 
or by extensive dialysis at 4” C. More protein 
material was lost during size exclusion chro- 
matography than during dialysis (up to 50% and 
15% respectively). Dialysis of small volumes was 
achieved by floating a low-protein-binding filter 
unit with the sample (10000 NMWL filter unit, 
cat. no. UFC3 LGLOO, Millipore, Bedford MA, 
USA) on PBS containing 0.04% Tween 20 and 
0.02% (w/v> sodium azide. The biotinylated GF 
were stored at 4” C in the presence of 0.02% 
(w/v) sodium azide. The protein concentration 
after biotinylation was determined with the BCA 
micro protein assay (Pierce). The presence of 
biotinylated IL-2 was determined by spotting 1 ~1 
of stepwise dilutions (l/2) of the samples directly 
on a nitrocellulose membrane, followed by immu- 
noenzymatic staining of the membrane with 
streptavidin-alkaline phosphatase and 4-nitro blue 
tetrazolium chloride 5-bromo-4-chloro-3-indolyl 
phosphate (NBT BCIP) development. 
2.2. Cell line and biological activity assays 
Cells from the IL-2 dependent mouse cytotoxic 
T cell line CTLL-2 were grown in RPM1 1640 
supplemented with 10% (v/v> heat inactivated 
fetal calf serum, 0.1 mM P-mercaptoethanol, 2 
mM L-glutamine, and 20 U/ml of IL-2. Cultures 
were maintained at 37” C in a humidified atmo- 
sphere of 5% CO, in air. To determine the 
biological activity of the biotinylated GF, lo4 
cells per well of 96 well microtiter plates were 
cultured in 200 ~1 RPM1 medium containing 
serial dilutions of either biotin-IL-2 or unmodi- 
fied IL-2. After 24 h, 0.25 FCi [3H]thymidine was 
added to each well. The cells were harvested 
after 16-18 h of thymidine incorporation, and the 
radioactivity was measured in a liquid scintilla- 
tion counter. Alternatively, in a non-radioactive 
assay the number of nucleated cells per well was 
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determined by staining the nuclei with propidium 
iodide (PI) and measuring the fluorescence inten- 
sity. For this purpose, the ceils were cultured for 
40-48 h, after which 0.5% (v/v> Triton X-100 
and 0.002% (w/v> PI were added to the wells. 
After approximately 1.5 min the microtiter plates 
were read in a Leitz Diavert inverted microfluo- 
rometer using green excitation by a halogen lamp. 
2.3. Mouse bone marrow cells 
Bone marrow from 7-week-old BCBA 
(C57BI/LiARij X CBA/BrARij)Fl mice was 
harvested by flushing femora and tibiae with 1 ml 
of ice-cold Hanks’ balanced salt solution 
(Laboratoires Eurobio, Paris, France) buffered at 
pH 6.9 with 10 mM Hepes (Merck) (HH, osmo- 
larity 300-305 mosmol/kg). A single cell suspen- 
sion was obtained by filtration through a six-layer 
nylon sieve. 
2.3. Human peripheral blood cells 
Peripheral blood cells from normal human vol- 
unteers were cultured in a humidified atmo- 
sphere of 5% CO, in air at 37°C in RPM1 1640 
supplemented with 10% (v/v> heat inactivated 
fetal calf serum, 0.1 mM /3-mercaptoethanol, 2
mM L-glutamine and 90 mg/ml phytohemagglu- 
tinin (PHA, 1% of stock solution, Wellcome 
Foundation, Dartford, EngIand). 
2.5. Immunocytochemical staining and flow cytom- 
etry 
Cells were stained in 50 ~1 PBS/serum/azide 
(PSA, human cells) or HH/serum/azide (HSA, 
mouse cells): PBS or HH, containing 5% (v/v) 
fetal or newborn calf serum and 0.02% (w/v) 
sodium azide. Cells (lo6 per sample) were incu- 
bated with biotin-IL-2 (14-140 nM1 in a volume 
of 50 ~1 for 60 min at room temperature. Similar 
results were obtained by incubation on ice. The 
samples were then stained for 15-30 min on ice, 
using either avidin-FITC cl:300 v/v, Vector Lab- 
oratories, Burlingame CA, USA), streptavidin- 
BODIPY cl:100 v/v, Molecular Probes), or 
streptavidin-phycoerythrin (streptavidin-PE, 1:5 
v/v, Becton Dickinson, San Jose, CA, USA; or 
1:200 v/v, Molecular Probes, Eugene OR, USA). 
After each incubation the samples were washed 
in PSA or HSA. Low intensity fluorescence sig- 
nals were amplified by incubating the cells for 
15-30 min on ice with alternate layers of biotiny- 
lated goat anti-(streptjavidin (both 1:lOO v/v, 
Vector) and fluorescence labeled (streptlavidin. 
Control cells were incubated only with the fluo- 
rescence labeled (streptjavidin and the amplifying 
layers of biotinylated anti-(strept)avidin and fluo- 
rescence labeled (strept)avidin. Specificity of 
binding of the different biotin-IL-2 samples was 
determined by incubating the cells with biotin-IL- 
2 in the presence of a 100 X molar excess of 
unbiotinylated IL-2. 
For staining with anti-IL-2 receptor (Y chain 
antibody, mouse cells were incubated with the 
antibody 5A2 (Moreau et al., 1987) (undiluted 
culture supernatant of hybridoma cells, kindly 
provided by Dr. Theze, Departement d’Immunol- 
ogie, Institut Pasteur, Paris, France) for 30 min 
on ice. Human cells were incubated with the rat 
anti-TAC antibody 36A1.2 (Olive et al., 19861, 
followed by staining with FITC-conjugated goat 
anti-rat antibodies (GARa-FITC; 1: 100 v/v, Tago, 
Burlingame, CA, USA). In double-staining exper- 
iments, these antibodies were added during am- 
plification of the streptavidin-PE signal: the anti- 
TAC antibody was added to the cells together 
with biotinylated goat anti-streptavidin, followed 
by incubation with GARa-FITC and streptavidin- 
PE. In some experiments a combination of strept- 
avidin-BODIPY and GARa-PE cl:200 v/v, Tago) 
was used, 
To analyze the expression of IL-2 receptors on 
subsets of human peripheral blood lymphocytes, 
cells were double-stained with mouse anti-CD4 
antibodies cl:20 v/v, Becton Dickinson) and ei- 
ther anti-TAC or biotin-IL-Z combined with PE- 
conjugated goat anti-mouse antibodies (GAM-PE; 
1:lOO v/v, Sigma Chemical Company, St. Louis, 
MO, USA) and either GARa-FITC or strepta- 
vidin-BODIPY. 
Samples were analyzed using a flow cytometer 
(RELACS: Rijswijk Experimental Light Acti- 
vated Cell Sorter, ITRI-TNO, Rijswijk, Nether- 
lands). Cells were illuminated with the 488 nm 
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Table 1 
Spot-blot analysis of the different biotin-IL-2 samples 
Minimal detectable amount (ng) of biotin-IL-2 per ~1 a 
NHS S-NHS S-NHS-LC DBB Photo 
DMSO DMSO Buffer DMSO Buffer 
B:P b 0 100 > 100 100 > 100 > 100 > 100 B:P 0 > 100 
B:P 4 5 20 50 10 10 90 B:P 2.5 > 100 
B:P 20 1 5 10 1 1 10 B:P 25 40 
B:P 100 <l <l <l <l <l <l B:P 250 <l 
a The minimal detectable amount (ng) of biotin-IL-2 per ~1 was determined by spotting 1 ~1 of stepwise dilutions of the biotin-IL-2 
samples on nitrocellulose, followed by immunoenzymatic staining with streptavidin-alkaline phosphatase and NBT BCIP develop- 
ment. 
’ B:P = biotin:protein ratio. 
line of an argon ion laser. Green FITC or BOD- 
IPY fluorescence was measured through a 530 
nm/30 nm bandpass filter (Becton Dickinson, 
Mountain View, CA, USA). Orange PE fluores- 
cence was measured through a 577 nm/lO nm 
bandpass filter. 
3. Results 
3.1. Biotinylation of IL-2 
IL-2 was biotinylated using either NHS-biotin, 
S-NHS-biotin, S-NHS-LC-biotin, DBB or photo- 
biotin (Fig. 1). The degree of biotinylation of the 
different samples was studied by spotting 1 ~1 of 
stepwise dilutions of biotin-IL-2 on a nitrocellu- 
lose filter and comparing the intensity of the 
Table 2 
Biological activity of the different biotin-IL-2 samples 
spots following incubation with streptavidin-al- 
kaline phosphatase and NBT BCIP development. 
The various biotin-IL-2 samples contained differ- 
ent amounts of biotin, as shown by the amounts 
minimally needed to give a visible stain on the 
nitrocellulose membrane (Table 1). As expected, 
the highest degree of biotinylation was achieved 
at the highest B:P reaction ratios, whereas the 
B:P 0 controls were not visible on the mem- 
branes. The water-soluble S-NHS-LC-biotin ap- 
peared to label with similar efficiency after dis- 
solving in DMSO or in buffer. S-NHS-biotin la- 
beled slightly more efficiently after dissolving in 
DMSO than in buffer. NHS-biotin and S-NHS- 
LC-biotin gave the best biotinylation efficiency, 
followed by S-NHS-biotin and DBB, which were 
4-lo-fold less efficient. The lowest degree of 
biotinylation occurred when IL-2 was labeled with 
the photobiotin reagent (Table 1). 
Recovery (%l of biological activity a 
NHS S-NHS 
DMSO DMSO Buffer 
S-NHS-LC DBB Photo 
DMSO Buffer 
B:P b 0 100 100 100 100 100 100 B:P 0 100 
B:P 4 100 100 100 100 100 100 B:P 2.5 100 
B:P 20 33 90 85 90 100 80 B:P 25 33 
B:P 100 5 33 72 40 80 20 B:P 250 7 
a IL-2 dependent CTLL-2 cells were grown in the presence of different amounts of biotin-IL-2. The amount of biotin-IL-2 needed 
per well for 50% maximal stimulation of the cells was calculated for the different samples. Results are expressed as % biological 
activity. as compared to unbiotinylated IL-2 (lOO%o). 
b B:P = biotin:protein ratio. 
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3.2. Biological actiui& of biotinylated IL-2 prepara- 
tions 
Using the IL-2 dependent mouse cytotoxic T 
cell line CTLL-2, the B:P ratio was found to 
affect the biological activity of biotin-IL-2 (Table 
2). At the lowest B:P ratio used in the biotinyla- 
tion reaction, biological activity was not lost as a 
result of biotinylation. Higher B:P ratios had a 
marked negative effect on the biological activity 
of some biotinyl derivatives (Table 2). Loss of 
biological activity was highest when IL-2 was bi- 
otinylated with NHS-biotin or photobiotin. When 
used at B:P 100, biotinylation with DBB also led 
to a large loss of biological activity. The use of 
the water-soluble NHS-biotins dissolved in 
DMSO resulted in two-fold larger losses of bio- 
logical activity than when these reagents were 
dissolved in buffer. The highest recovery of bio- 
logical activity (2 70430% at B:P 100) was 
achieved with S-NHS-LC-biotin and S-NHS-bio- 
tin (Table 2). 
Fig. 2. Fluorescence histograms of CTLL-2 cells, incubated 
with different biotin-IL-2 samples and streptavidin-PE. The 
fluorescence signal was amplified by two cycles of sequential 
incubations with biotinylated anti-streptavidin antibodies and 
streptavidin-PE. The cells were labeled with biotin-IL-2, bi- 
otinylated with S-NH.5LC-biotin that was dissolved in DMSO: 
from right to left are B:P 100, B:P 20 and B:P 4, and the B:P 0 
control. 
3.3. Cell staining 
Immunocytochemical staining properties of the 
different biotin-IL-2 samples were compared us- 
ing flow cytometry. Fig. 2 shows an example of 
the fluorescence histograms, resulting from the 
incubation of CTLL-2 cells with biotin-IL-2 made 
by biotinylation with S-NHS-LC-biotin at differ- 
ent B:P ratios. The mean fluorescence intensities 
of cells, labeled with the different biotin-IL-2 
preparations are presented in Table 3. IL-2 la- 
beled with the NHS-biotins gave the highest fluo- 
rescence intensities: with the extra long spacer 
arm between the protein and the actual biotin 
molecule (S-NHS-LC-biotinl the fluorescence sig- 
nal was even higher than with the normal spacer 
arm (NHS-biotin and S-NHS-biotin). Dissolving 
the water soluble S-NHS-biotin or S-NHS-LC- 
biotin in DMSO before biotinylating the IL-2 
resulted in higher fluorescence intensities of 
stained cells than dissolving in buffer. In compar- 
ison with the various NHS-biotins, biotinylation 
with DBB resulted in a lower fluorescence signal. 
The fluorescence signal resulting from photobi- 
otin-IL-2 was almost indistinguishable from the 
background fluorescence of the cells (Table 31. 
For most biotinyl derivatives, the preparations 
Table 3 
Fluorescence intensity of CTLL-2 cells, stained with the different biotin-IL-2 samples 
blotin-IL-2 
Mean fluorescence intensity (arbitrary units) a 
NHS S-NHS S-NHS-LC DBB Photo 
DMSO DMSO Buffer DMSO Buffer 
B:P h 0 7 I 8 7 8 7 B:P 0 I 
B:P 4 41 20 9 73 28 13 B:P 2.5 18 
B:P 20 157 48 32 164 116 59 B:P 25 9 
B:P 100 100 164 122 316 288 99 B:P 250 24 
” CTLL-2 cells were incubated with the different biotin-IL-2 samples and streptavidin-PE, amplified with biotin-anti-streptavidin 
and streptavidin-PE. 
h B:P = biotin:protein ratio. 
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Fig. 3. Fluorescence histograms of CTLL-2 cells, incubated 
with biotin-IL-2 (thick solid line). in the presence of a 100~ 
molar excess of unbiotinylated IL-2 (broken line), and fluores- 
cence labeled streptavidin, or stained only with fluorescence 
labeled streptavidin without biotin-IL-2 (thin solid line). The 
fluorescence signal was amplified using biotinylated anti- 
streptavidin antibodies and a second incubation with fluores- 
cence labeled streptavidin. 
with the highest B:P ratios resulted in the highest 
fluorescence intensities. Only with the standard 
NHS-biotin was an impaired staining of the B:P 
100 sample (relative to the B:P 20) consistently 
observed (Table 3). For all biotin-IL-2 samples, 
the fluorescence signal of cells incubated in the 
presence of a 100 X molar excess of unbiotiny- 
lated IL-2 was similar to that of control cells 
incubated without biotin-IL-2, which indicated 
specific binding of biotin-IL-2 to the cells. This is 
illustrated in Fig. 3 for CTLL-2 cells, incubated 
with biotin-IL-2 prepared with NHS-biotin. 
When IL-2 receptors on lymphocytes from pe- 
ripheral blood or bone marrow were stained, a 
difference was found between incubation with 
biotin-IL-2 and with antibodies against the (Y 
chain of the IL-2 receptor. The majority of un- 
stimulated lymphocytes from mouse bone marrow 
as well as human peripheral blood were biotin- 
IL-2 positive (Fig. 4A and 4C, respectively), 
whereas a much smaller fraction expressed the 
IL-2 receptor (Y chain at a level above back- 
ground fluorescence (Fig. 4B and 4D). Double- 
staining experiments revealed that the (Y chain 
positive cells were all biotin-IL-2 positive (data 
not shown). After stimulation of human periph- 
eral blood lymphocytes (PBL) with PHA virtually 
biotin-IL-2 anti IL-2 receptor c( chain 
Fig. 4. Fluorescence histograms of mouse bone marrow lymphocytes (A and Bl and human peripheral blood lymphocytes (C and 
D), stained with biotin-IL-2 and streptavidin-PE, and amplified (A and Cl. or stained with rat anti-IL-2 receptor (Y chain 
antibodies and FITC conjugated goat anti-rat antibodies (B and D). Thick lines represent stained cells, thin lines unstained control 
cells. 
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Fig. 5. Dot plots of human peripheral blood lymphocytes that were stimulated with PHA for 3 days, and stained with mouse 
anti-CD4 antibodies in the first step, in combination with either biotin-IL-2 (A) or rat anti-IL-2 receptor 01 chain antibodies (B). In 
the second step, cells were stained with PE-conjugated goat anti-mouse antibodies in combination with either streptavidin-BODIPY 
(A) or FITC-conjugated goat anti-rat antibodies (B). Quadrants were set on the basis of background fluorescence of unstained 
cells to discriminate between brightly stained cells and cells with low or no fluorescence signal. 
all cells became (Y chain-positive (Fig. 5B), 
whereas a much smaller fraction of the cells 
stained strongly with biotin-IL-2 (Fig. 5A). Most 
of the cells that showed a strong fluorescence 
signal after staining with biotin-IL-2 or anti-TAC 
were CD4 positive. The proportion of CD4 nega- 
tive cells that expressed high levels of IL-2 recep- 
tor was much lower. The remaining cells were 
either IL-2 receptor negative or expressed IL-2 
receptors at low levels (Fig. 5). 
4. Discussion 
This study has evaluated the biotinylation of 
IL-2 using five different biotin derivatives. The 
data presented extends previous observations 
concerning the use of GF labeled with (mostly 
NHS-lbiotin (Foxwell et al., 1988b; Yamasaki et 
al., 1988; Taki et al., 1989; Peters and Norback, 
1990; Pieri and Barritault, 1991; De Jong et al., 
1992; Wognum et al., 1993), by comparing the 
results of labeling with NHS-biotin, S-NHS-bio- 
tin, S-NHS-LC-biotin, DBB and photobiotin. The 
highest biotinylation efficiency, retention of bio- 
logical activity and the highest specific staining of 
IL-2 receptor expressing cells was achieved using 
S-NHS-LC-biotin. The results with S-NHS-LC- 
biotin could be explained by a more efficient 
biotinylation, because the extended spacer arm 
permits the biotin to reach the lysine groups, or 
by a more efficient interaction of the biotinylated 
IL-2 with the streptavidin conjugates. 
Most biotin-IL-2 samples showed reduced ac- 
tivity in stimulating the growth of the IL-2 depen- 
dent cell line CTLL-2 when high B:P ratios were 
used. We cannot exclude the possibility that part 
of the biological activity of the biotin-IL-2 sam- 
ples is due to residual unmodified IL-2 molecules. 
Attempts to separate biotin-IL-2 from IL-2 on an 
avidin-agarose column were not successful be- 
cause IL-2 bound nonspecifically to the column. 
The decreased biological activity of samples with 
a high B:P ratio is probably the result of impaired 
receptor binding, caused by conformational 
changes of the biotin-IL-2 or by steric hindrance 
when the biotin molecules are close to the recep- 
tor binding site(s) of IL-2. It is also possible that 
these biotinylated IL-2 molecules can bind to the 
cells but fail to stimulate cell proliferation. The 
IL-2 receptor consists of different subunits 
(Takeshita et al., 1992a1, with different IL-2 bind- 
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ing characteristics (Lowenthal and Greene, 1987). 
A low affinity IL-2 receptor contains only the 55 
kDa (Y chain (Leonard et al., 1984; Nikaido et al., 
1984). A heterodimeric IL-2 receptor with inter- 
mediate affinity for IL-2 consists of the 70-75 
kDa p chain (Sharon et al., 1986; Baccarini et al., 
1989) and the 64 kDa y chain (Takeshita et al., 
1992a,b). A ‘pseudo-high’ affinity IL-2 receptor is 
formed by interaction of (Y and p chains (Nakarai 
et al., 1994), which can only be internalized when 
combined with the y subunit (Takeshita et al., 
1992a), thereby forming the trimeric high affinity 
IL-2 receptor which has a higher association rate 
and a lower dissociation rate than the ap com- 
plex (Matsuoka et al., 1993). Heterodimerization 
of the p and y chain is required for signalling 
(Nakamura et al., 1994; Nelson et al., 1994). The 
decreased biological activity of samples with a 
high B:P ratio might thus be caused by steric 
hindrance, which impedes receptor binding 
and/or the formation of receptor complexes that 
are required for cell signalling or internalization. 
Despite the partial loss of biological activity, 
the biotinylated IL-2 samples prepared at higher 
B:P ratios generally yielded better fluorescence 
signals. It is possible that at higher B:P ratios, a 
higher proportion of biotinylated IL-2 molecules 
have sufficient numbers of biotin molecules fac- 
ing away from the receptor binding sites to per- 
mit binding of (streptjavidin molecules to recep- 
tor bound biotin-IL-2. Only the samples with high 
B:P ratios that lost almost all biological activity 
(NHS-biotin and photobiotin) showed low fluo- 
rescence intensities. 
The weak performance of DBB compared to 
the different NHS-biotins may be explained from 
the amino acid composition of IL-2: NHS-biotins 
mainly react with lysine residues, of which there 
are 11 in IL-2, while there are only three his- 
tidines and four tyrosines (Taniguchi et al., 1983) 
which are necessary for DBB binding. Direct 
measurement of the number of biotin molecules 
present on the IL-2, e.g. with 2-(4’-hydroxy-phen- 
ylazolbenzoic acid (HABA) (Baxter, 1964), was 
not attempted, because the procedure requires a 
large amount of biotinylated protein. 
Our experiments show that biotinylated IL-2 
can be used for cell staining experiments. When 
IL-2 receptors on unstimulated lymphocytes from 
mouse bone marrow or human peripheral blood 
were labeled, only part of the biotin-IL-2 positive 
cells expressed high levels of the IL-2 receptor (Y 
chain (Fig. 4). This is in agreement with the 
finding that only intermediate affinity IL-2 recep- 
tors are present on the surface of resting T cells 
and NK cells (Dukovich et al., 19871, while the 
IL-2 receptor (Y chain is induced only after activa- 
tion of the cells (Hamblin, 1985; Lai et al., 1991). 
After stimulation of PBL with PI-IA, virtually all 
cells stained brightly with anti-TAC, particularly 
in the CD4 positive subset (Fig. 5B). However, 
only about two thirds of these cells showed a high 
fluorescence signal after incubation with biotin- 
IL-2 (Fig. 5A). The cells with a low binding 
capacity for biotin-IL-2 may have a limiting num- 
ber of IL-2 receptor p and/or y chains to form 
high affinity receptors with the (Y chains. Biotin- 
IL-2 binding thus appears to be a better marker 
for the expression of functional IL-2 receptor 
complexes than binding of anti-TAC. A possible 
advantage of staining with biotinylated GF for in 
vivo studies with isolated receptor expressing cells 
is that avidin-tagged cells are not selectively re- 
moved by the immune system of the recipient 
animals. In contrast, antibody stained cells may 
be eliminated by phagocytosis induced by the F, 
parts of the antibodies or by complement-media- 
ted lysis (Bauman et al., 1985). As shown in 
previous studies for other cytokines (Wognum et 
al., 1990; De Jong et al., 1992; Wognum et al., 
19931, flow cytometric analysis of receptor expres- 
sion using biotinylated GF is very sensitive: cells 
expressing as few as 100 cell surface receptors 
can be detected. Therefore, biotinylated GF pro- 
vide a useful tool for investigating the distribution 
of functional GF receptors, e.g. on subsets of 
early hemopoietic cells in bone marrow. 
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